Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Infant Bacterial Therapeutics AB | 25,625 | net | 08 May 2025 | tx 31+25,625 |
| BioGaia AB | 15,900 | net | 05 Dec 2025 | tx 18+15,920−20 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Dec 2025 | PURCHASE | BioGaia AB | 5,000 | 98.00 SEK | |
| 27 Nov 2025 | PURCHASE | BioGaia AB | 1,380 | 101.20 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 35 | 96.95 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 62 | 97.15 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 100 | 97.15 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 1,335 | 97.20 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 354 | 97.20 SEK | |
| 07 Nov 2025 | PURCHASE | BioGaia AB | 101 | 97.15 SEK | |
| 22 Oct 2025 | SALE | BioGaia AB | 20 | 109.00 SEK | |
| 16 May 2025 | PURCHASE | BioGaia AB | 136 | 107.10 SEK | |
| 15 May 2025 | PURCHASE | BioGaia AB | 112 | 105.19 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 76 | 60.60 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 82 | 60.80 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 81 | 61.00 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 81 | 61.20 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 524 | 61.20 SEK | |
| 08 May 2025 | PURCHASE | Infant Bacterial Therapeutics AB | 511 | 61.40 SEK | |
| 08 May 2025 | PURCHASE | BioGaia AB | 2,015 | 100.00 SEK | |
| 04 Nov 2024 | PURCHASE | BioGaia AB | 1,250 | 107.90 SEK | |
| 02 Sept 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 11,000 | 25.00 SEK | |
| 02 Sept 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 3,000 | 25.00 SEK | |
| 17 May 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 37 | 96.20 SEK | |
| 17 May 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 88 | 96.80 SEK | |
| 17 May 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 56 | 97.20 SEK | |
| 17 May 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 89 | 97.60 SEK |
1 purchase reported after at least 12 months of silence — most recent on 10 Mar 2023.